Phase 3 Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, including women who are able to become pregnant
- People who have had a sudden onset of chest pain that started less than 24 hours ago
- People whose heart tracing (ECG) shows a specific type of heart attack (called STEMI), identified by one of several patterns of electrical changes in the heart — the trial site or doctor will assess which pattern applies (confirm with trial site)
Who may not be able to join:
- People where doctors suspect a different kind of heart attack (called a Type I AMI) at the time they would be enrolled in the trial
- People whose first sign of a heart problem was a cardiac arrest that happened outside of a hospital
- People with a known allergy to glucocorticoids (a type of steroid medication)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thomas Engstrøm, MD, PhD, DMSc, Rigshospitalet, Denmark
Phone: 35458176
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
All-cause mortality
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.